These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28744156)

  • 1. Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells.
    Liang Y; Goyette S; Hyder SM
    Breast Cancer (Dove Med Press); 2017; 9():487-494. PubMed ID: 28744156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro.
    Goyette S; Liang Y; Mafuvadze B; Cook MT; Munir M; Hyder SM
    Breast Cancer (Dove Med Press); 2017; 9():347-357. PubMed ID: 28579829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
    Wu J; Brandt S; Hyder SM
    Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.
    Cook MT; Liang Y; Besch-Williford C; Goyette S; Mafuvadze B; Hyder SM
    Springerplus; 2015; 4():444. PubMed ID: 26312209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells.
    Carroll CE; Ellersieck MR; Hyder SM
    Menopause; 2008; 15(3):570-4. PubMed ID: 18467956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells.
    Classen S; Possinger K; Pelka-Fleischer R; Wilmanns W
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):315-9. PubMed ID: 8499339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
    Wu J; Richer J; Horwitz KB; Hyder SM
    Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
    Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
    Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
    Bentel JM; Birrell SN; Pickering MA; Holds DJ; Horsfall DJ; Tilley WD
    Mol Cell Endocrinol; 1999 Aug; 154(1-2):11-20. PubMed ID: 10509795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
    Hyder SM; Chiappetta C; Stancel GM
    Int J Cancer; 2001 May; 92(4):469-73. PubMed ID: 11304678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
    Liang Y; Besch-Williford C; Brekken RA; Hyder SM
    Cancer Res; 2007 Oct; 67(20):9929-36. PubMed ID: 17942925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
    Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
    Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth.
    Liang Y; Besch-Williford C; Hyder SM
    Breast Cancer Res Treat; 2022 Feb; 192(1):53-63. PubMed ID: 35037188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.
    Finlay-Schultz J; Cittelly DM; Hendricks P; Patel P; Kabos P; Jacobsen BM; Richer JK; Sartorius CA
    Oncogene; 2015 Jul; 34(28):3676-87. PubMed ID: 25241899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
    Mafuvadze B; Liang Y; Hyder SM
    Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
    Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
    Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.
    Liang Y; Benakanakere I; Besch-Williford C; Hyder RS; Ellersieck MR; Hyder SM
    Menopause; 2010; 17(5):1040-7. PubMed ID: 20461021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.